retatrutide vomiting Side Effects: What Clinical Trials Tell Us Retatrutide Side Effects: Risks and

There are currently two major players with a decisive head start in the obesity drug space: Eli Lilly (LLY) and Novo Nordisk (NVO)

Why protein intake drops on GLP-1 When appetite is lower, large high-protein meals can feel difficult to finish

Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain mostbut not allof their weight loss, according to a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Brand names are referenced for educational context only and do not indicate that a specific branded product will be prescribed

Los agonistas de los receptores GLP-1 y GIP son tratamientos innovadores desarrollados inicialmente para la diabetes, pero que ahora se utilizan para tratar la obesidad

Amid rising demand for drugs like Wegovy and Ozempic that can lead to significant weight loss, some obesity experts are concerned about the drugs costs both to patients finances and to their health